Cantor Fitzgerald Initiates Coverage On ATAI Life Sciences with Overweight Rating, Announces Price Target of $45

Benzinga · 07/13/2021 12:30
Cantor Fitzgerald analyst Charles Duncan initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Overweight rating and announces Price Target of $45.